Brief: Ekso Bionics Reports Q4 And Year End 2020 Results
25/02/2021 22:25
Feb 25 (Reuters) - Ekso Bionics Holdings Inc EKSO.O :
* EKSO BIONICS REPORTS FOURTH QUARTER AND YEAR END 2020
RESULTS
* Q4 REVENUE $2.3 MILLION VERSUS $3.7 MILLION
* Q4 LOSS PER SHARE $0.48
* CASH AT DECEMBER 31, 2020 WAS $12.9 MILLION, COMPARED TO
$10.9
MILLION AT DECEMBER 31, 2019
Source text for Eikon: ID:nGNX6W50xq
Further company coverage: EKSO.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Chronoscale
See all newsBrief: Soluna To Form Strategic Partnership With Applied Digital For Wind-Powered AI Data Center In Texas
Brief: Chronoscale Announces Agreements Bringing Total Company Contracted Run-Rate Revenue To $1 Billion And Sale Of Ekso Bionics Business Unit
U.S. STOCKS ON THE MOVE-BWX Technologies, Synopsys,Burlington Stores
U.S. STOCKS ON THE MOVE-Jazz Pharmaceuticals, Celularity, Infleqtion
U.S. STOCKS ON THE MOVE-Veeva Systems, Dollar General, ChronoScale